Induced pluripotent stem cells model personalized variations in liver disease resulting from a1-antitrypsin deficiency.
Induced pluripotent stem cells model personalized variations in liver disease resulting from a1-antitrypsin deficiency. Hepatology. 2015 Jul; 62(1):147-57.